Company Overview
Atlas Trinity Tech Limited, through its subsidiaries, engages in the sourcing and wholesaling of personal care electrical appliances and the provision of product design, development, advisory, and marketing services. The company operates through three segments: appliances, product design, development and advisory services, and marketing solutions. The appliances segment, operated through Pure Beauty Manufacturing Company Limited, sources and wholesales personal care electrical appliances for international brand owners, including a hair styling series comprising hair dryers, hair straighteners, and curling irons; a trimmer series comprising facial shavers, nose trimmers, and eyebrow trimmers; eyelash curlers; a nail care series; tooling; and other personal care appliances such as body and facial brushes, reset brushes, callus removers, sonic peeling devices, and handy fans. This segment also offers product design and development collaboration as a value-added service, with a focus on salon-type and compact travel hair dryers. The product design, development and advisory services segment, operated through Raytech Innovation Limited, provides product design and development services and project advisory services related to personal health care electronics. The marketing solutions segment, operated through Worry free Group (Hong Kong) Limited, provides marketing solutions and execution services. The company primarily serves brand owners of personal care electrical appliances, with customers largely based in Japan. Atlas Trinity Tech Limited was formerly known as Raytech Holding Limited and changed its name to Atlas Trinity Tech Limited in September 2026. Atlas Trinity Tech Limited was incorporated in 2022 and is based in Kowloon Bay, Hong Kong.
Why Investors Should Care
Generates a return on equity of 16.2%, reflecting efficient use of shareholder capital.
Revenue has grown at a 20.4% CAGR over the past five years.
Trades at an undemanding P/E of 2.8.
Carries low leverage with a debt-to-equity ratio of 0.11.
Recent Developments
- Mar 2025 Revenue of $78.74M (+17.6% YoY); net profit $8.27M.
- Trailing 12 Months Year-on-year growth — revenue +196.0%, earnings +33.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 20.4%, profit CAGR -4.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 20.41% |
| 1 Year: | 196.00% |
Compounded Profit Growth
| 5 Years: | -4.32% |
| 1 Year: | 33.50% |
Stock Price Performance
| 1 Year: | -94.25% |
| 6 Months: | -41.48% |
| 3 Months: | -20.28% |
| 1 Month: | -12.12% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)39.66 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 20.4% over 5 years.
CONS
- Earnings shrank at -4.3% CAGR over 5 years.
- Trading 94.9% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Revenue | 45.11M | 45.52M | 66.97M | 78.74M |
| Cost of Revenue | 33.00M | 34.05M | 52.07M | 60.93M |
| Gross Profit | 12.10M | 11.47M | 14.90M | 17.81M |
| Operating Expenses | 927.74K | 4.28M | 3.55M | 10.16M |
| Operating Income | 11.18M | 7.19M | 11.36M | 7.65M |
| EBITDA | 11.22M | 7.60M | 12.85M | 10.52M |
| Interest Expense | 1.68K | 7.15K | 2.03K | 0 |
| Pretax Income | 11.18M | 7.47M | 12.75M | 10.52M |
| Tax Provision | 1.74M | 1.18M | 2.82M | 2.26M |
| Net Income | 9.44M | 6.29M | 9.94M | 8.27M |
| Diluted EPS | 8.63 | 0.36 | 9.09 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Total Assets | 20.88M | 33.05M | 58.11M | 94.89M |
| Current Assets | 20.65M | 29.75M | 52.84M | 94.87M |
| Cash & Equivalents | 12.29M | 21.36M | 35.89M | 84.85M |
| Inventory | 0 | 0 | 1.86M | 1.88M |
| Receivables | 5.83M | 6.79M | 14.56M | 8.14M |
| Total Liabilities | 6.04M | 11.91M | 27.04M | 17.93M |
| Current Liabilities | 5.95M | 11.91M | 27.04M | 17.93M |
| Long Term Debt | - | - | - | - |
| Total Debt | 188.82K | 87.97K | 0 | - |
| Total Equity | 14.85M | 21.14M | 31.08M | 76.96M |
| Shares Outstanding | 1.09M | 1.09M | 1.09M | 1.10M |
Cash Flows (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Operating Cash Flow | 8.23M | 10.96M | 15.75M | 6.22M |
| Investing Cash Flow | 2.20M | 1.44M | 846.86K | 145.17K |
| Financing Cash Flow | -1.56M | -3.18M | -2.08M | 42.87M |
| Capital Expenditure | -11.70K | - | - | - |
| Free Cash Flow | 8.22M | 10.96M | 15.75M | 6.22M |
| Net Change in Cash | 8.87M | 9.23M | 14.52M | 49.24M |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Gross Margin % | 26.8% | 25.2% | 22.3% | 22.6% |
| Operating Margin % | 24.8% | 15.8% | 17.0% | 9.7% |
| Net Margin % | 20.9% | 13.8% | 14.8% | 10.5% |
| ROE % | 63.6% | 29.8% | 32.0% | 10.7% |
| ROCE % | 74.8% | 34.0% | 36.6% | 9.9% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Cetera Investment Advisers | 0.34% | 19.86K | $55.61K |
| 2 | Citigroup Inc. | 0.27% | 15.85K | $44.38K |
| 3 | UBS Group AG | 0.06% | 3.54K | $9.91K |
| 4 | Acadian Asset Management. LLC | 0.05% | 2.96K | $8.29K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for RAY
Ray Dalio tripled his money at 12 on his first stock pick — then a bad call left him borrowing $4,000 from his dad - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPVzZpakJfa0JNX21qdHpEVXFJT0tnSnpsV2c2NUxfandWbzhrZFhZbmEwT2hSSEx3dzVrNmJxakpxV1Q1Y1ZsNEl1bXJvbUw4R0hjeExJeFEzZ1RSWVdHR1YwX01way1DSUFkT25tajE5MlU3RGlNNkk3VlZOaUZraC1hMGx2VldxYi1adj…
Michael Ray called on to pinch hit for Jianna Evaristo in Pro Stock Motorcycle - NHRA
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxOSmZwdXFyeWxsaDRsd1FIX01fVXIxaFBka1JtekRlT1RqOE5PMU4yX2FZVXBvZFU0anpDeThpX0RTcExZeXFlOXIxWGtsbGxzejRrYWVNcTUxZ1JVaDMwTzAyU0s4UWM5RUdTdEVtejhhWFBPOUlEUXlXaWJCWjJwWThnQXRXRXBTd0hQR2…
Deal Valued At $1.1 Billion Sends This X-Ray Stock Soaring 48% - Investor's Business Daily
<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxPVUtha0FyQXhQNURjZlZwV25uRVFkTHMyNTVrYjlnTXJSX29ZbVEtZzRKQW5FZ2Jub0kxMjkxcGlnYk5sR3FmNGxobWtZRE9LMElJRC1Da3o1ZDJ5eU5OZ3FoMU1rZFBMMXNRR1otRTl5NDcyc0k0UGV1SmMtYmVab1F2REZRWGdyQkE?oc…
EXEC: Oakley, Ray-Ban, Supreme Parent Launches Stock Buyback Program - SGB Media Online
<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxORXdFWWloSGdiRVVjS243YngtZk02WktUQVJ2UkRlNHNEYk43VkcwSGYzcVJBOTFKS2VyTGYzMU1mcV9RLXIxZjhWWEJVVVBkXzR4Uk03LTdKM3F0YXJ1NWkzekFKYmc2YVA5TmVBMU80ZzM4N1lTelMwZFNRWlNqVA?oc=5" target="_…
Raytech (Nasdaq: RAY) plans switch to Atlas Trinity Tech name and ATTT ticker - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxQOVlVMm14RklTWEQ2NmVrblFLNlJKbi1EWkVQcjJ3MUN1Z1RsRG5tRXBIeVkzOXl5Sm4zdU12MXFqNkdYN0pCaDU2Yzg5ZVdWdkJ3dDUtQzVBQ3pEYlR1ejkzeU8tQXg4OGRfYlJiVHRVRElpLUJJa0c4V3RmdGEyWEVmTTViZDZ5WlpMM2…
Ray Dalio Has Invested Over $900 Million In This Stock. Should You Buy? - 24/7 Wall St.
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQMThVUWplUVpWZHloelZoX1BZNGZVTlN4Vy1LamxqUEVRUEV3ZXlsa194SWQwVDBqdTkwb0laeWFhZ3JlNWp1TkNzdXNYdXZ0ZEtmVGpXb01zaVJ2dWFrYnFZcWlZVUYzNTdsSTlieUk0WmJ3VThkdFJhQlpkTTQ1S1VkWlJ1b3huUFozU2…
RAY — Frequently Asked Questions
What is the current share price of Atlas Trinity Tech Limited (RAY)?
As of 2026-09-19 21:16 PDT, Atlas Trinity Tech Limited (RAY) trades at $2.58 on NasdaqCM. Its 52-week range is $1.58 to $50.08.
What is the market capitalisation of RAY?
Atlas Trinity Tech Limited (RAY) has a market capitalisation of $15.16M on NasdaqCM.
What is the P/E ratio of RAY?
RAY trades at a trailing price-to-earnings (P/E) ratio of 2.84. Its price-to-book (P/B) ratio is 0.46.
What is the return on equity (ROE) of RAY?
RAY has a return on equity (ROE) of 16.16%. Its return on capital employed (ROCE) is 9.94%.
Is RAY a good stock to buy?
This page provides a data-driven analysis of Atlas Trinity Tech Limited (RAY), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.